4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-034376
Chairman and CEO bought 6,000 shares at an average $1.55 ($9,280)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-06-02 | Purchase | +2,000 | $1.60 | $3,200 | 10,647,493 | D |
| Niihara Yutaka Chairman and CEO | 2020-06-03 | Purchase | +4,000 | $1.52 | $6,080 | 10,651,493 | D |
| Open-market purchases · 6,000 sh · avg $1.55 · $9,280 | |||||||
Loading xslF345X03/doc4.xml…